Search alternatives:
significant negative » significant positive (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
negative decrease » negative breast (Expand Search)
Showing 2,341 - 2,360 results of 21,342 for search '(( significant negative decrease ) OR ( significant decrease decrease ))', query time: 0.45s Refine Results
  1. 2341
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2342
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2343
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2344
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2345
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2346
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2347
    The results of curve fitting analysis.

    The results of curve fitting analysis. by Hai-bo Ai (20790405)

    Published 2025
    Save to List
    Saved in:
  8. 2348
    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2349
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 2350
    Average proportion of first choice female applicants stratified by specialty category.

    Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2351
    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease.

    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2352
    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2353
    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023.

    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2354
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 2355
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 2356
    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023.

    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2357
    Gender differences in first choice match outcomes.

    Gender differences in first choice match outcomes. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2358
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 2359
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2360
    S1 Data -

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: